NCT03860948View on ClinicalTrials.gov

A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

May 2, 2019

Study Completion Date

May 14, 2019

Conditions
Bioequivalence
Interventions
DRUG

Savolitinib Test Preparation

Test preparation (T): dry granulation savolitinib tablets.

DRUG

Savolitinib Reference Preparation

Reference preparation (R): wet granulation savolitinib tablets.

Trial Locations (1)

200031

Shanghai Xuhui District Central Hospital, Shanghai

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT03860948 - A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers | Biotech Hunter | Biotech Hunter